Brand-name and Specialty Drug Prices Skyrocketing, AARP Study Finds

by Admin | March 1, 2016 3:13 pm

March 1, 2016—Retail prices for 622 brand name, generic, and specialty prescription drugs widely used by Medicare beneficiaries rose by an average of 9.4 percent in 2013, a far higher rate than in the previous seven years and far above 2013’s general inflation rate of 1.5 percent, new research shows.

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1]. Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2016/03/brand-name-and-specialty-drug-prices-skyrocketing-aapr-study-finds/